primary outcome (%)
DESCRIPTION
Atorvastatine 10 mg. Cumulative incidence of primary endpoint with intensive vs. standard lipid-lowering in treatment-resistant hypertension. 30. Atorvastatine 80 mg. - PowerPoint PPT PresentationTRANSCRIPT
Cumulative incidence of primary endpoint with intensive vs. standard lipid-lowering in treatment-resistant hypertension
Primary endpoint: death from CHD, non-fatal non-procedure-related MI, resuscitation after cardiac arrest , fatal or non-fatal stroke
Prim
ary
outc
ome
(%)
Atorvastatine 10 mgAtorvastatine 80 mg30
20
10
00 1 2 3 4 5
Bangalore et al., Eur Heart J 2014
Follow-up (years)